3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
3
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
81
Rectal Neoplasms
40
Colonic Neoplasms
34
Pancreatic Neoplasms
27
Stomach Neoplasms
22
Carcinoma, Hepatocellular
21
Breast Neoplasms
21
Esophageal Neoplasms
20
Neoplasm Metastasis
19
Nasopharyngeal Carcinoma
15
Esophageal Squamous Cell Carcinoma
13
Neoplasms
7
Head and Neck Neoplasms
7
Liver Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Carcinoma, Squamous Cell
5
Anus Neoplasms
5
Adenocarcinoma Of Esophagus
5
Nasopharyngeal Neoplasms
4
Inflammatory Breast Neoplasms
4
Cholangiocarcinoma
4
Recurrence
3
Gastrointestinal Neoplasms
3
Gallbladder Neoplasms
3
Digestive System Neoplasms
3
Breast Neoplasms, Male
3
Bile Duct Neoplasms
3
Solid Tumors
2
Ovarian Neoplasms
2
Neutropenia
2
Interventions
Oxaliplatin
1
Leucovorin
1
Irinotecan
1
Gemcitabine
1
Fluorouracil
1
Erlotinib Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Metastatic Pancreatic Adenocarcinoma
×
Fluorouracil
×
Clear all
NCT01729481
2017-07-19
ML22774
Ludwig-Maximilians - University of Munich
Phase 2
Unknown
150 enrolled